Arkolith/Insider Trading/STRO/Form 4

Albini Edward C

CFO AND SECRETARYSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2025Option exercise(M)24K—$0157K
May 15, 2025Tax withholding(F)16K$0.88$14K161K
May 15, 2025Option exercise(M)11K—$0168K
May 15, 2025Option exercise(M)9K—$0177K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2025Option exercise(M)24K—$027K
May 15, 2025Option exercise(M)11K—$05K
May 15, 2025Option exercise(M)9K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-013618) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML